Norway's Gjensidige Q2 insurance revenue rises on pricing, volume growth
Norway's Gjensidige Q2 insurance revenue rises on pricing, volume growth
Overview
Norway insurance group's Q2 insurance revenue rose 7.3% yr/yr on pricing and volume growth
Q2 insurance service result improved, excluding negative Danish court ruling impact
Combined ratio improved to 78.9% from 79.0%, reflecting strong cost control
Outlook
Company did not provide specific guidance for the current quarter or full year
Result Drivers
PRICING AND VOLUME GROWTH - Insurance revenue growth driven by pricing measures and higher volumes in Private Norway and Sweden
COST CONTROL - Improved margins and lower cost ratio contributed to higher insurance service result
PARTNERSHIPS - New and renewed partnerships broadened market access and reinforced positions in attractive customer segments
Company press release: ID:nWkr3RTggY
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Insurance Revenue |
| NOK 11.26 bln |
|
Q2 Net Income |
| NOK 2.12 bln |
|
Q2 Combined Ratio |
| 78.90% |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the multiline insurance & brokers peer group is "buy"
Wall Street's median 12-month price target for Gjensidige Forsikring ASA is NOK288.50, about 6.1% above its July 10 closing price of NOK271.80
The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 16 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Gjensidige Forsikring ASA
See all newsJefferies sees 'fading tailwinds' for Nordic insurers as prices moderate
Europe Research Roundup: AstraZeneca, Hensoldt, Sika
Brief: Gjensidige Forsikring Mulls Subordinated Tier 2 Bond Issue
MS turns bearish on Nordic insurers as 'northern lights are fading'
Top of the Street: EssilorLuxottica, Indra, Pearson, Buzzi, Nordic insurers